Genetic drug target validation using Mendelian randomisation

…, B Tyl, S Chopade, R Faraway, M Zwierzyna… - Nature …, 2020 - nature.com
Mendelian randomisation (MR) analysis is an important tool to elucidate the causal relevance
of environmental and biological risk factors for disease. However, causal inference is …

Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study

…, E Wheeler, VL Wright, H Wu, M Zwierzyna - The Lancet Digital …, 2023 - thelancet.com
Background Globally, there is a paucity of multimorbidity and comorbidity data, especially
for minority ethnic groups and younger people. We estimated the frequency of common …

Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease

…, DO Mook-Kanamori, M Zwierzyna… - Nature …, 2021 - nature.com
Abstract Development of cholesteryl ester transfer protein (CETP) inhibitors for coronary heart
disease (CHD) has yet to deliver licensed medicines. To distinguish compound from drug …

RNA folding using quantum computers

…, AMA Schreij, M Zwierzyna… - PLOS Computational …, 2022 - journals.plos.org
The 3-dimensional fold of an RNA molecule is largely determined by patterns of intramolecular
hydrogen bonds between bases. Predicting the base pairing network from the sequence, …

Big data in drug discovery

…, A Sim, BI Williams-Jones, M Zwierzyna… - Progress in medicinal …, 2018 - Elsevier
Abstract Interpretation of Big Data in the drug discovery community should enhance project
timelines and reduce clinical attrition through improved early decision making. The issues we …

CMC strategies and advanced technologies for vaccine development to boost acceleration and pandemic preparedness

…, D Stranges, L Strodiot, M Tello Soto, M Zwierzyna… - Vaccines, 2023 - mdpi.com
This review reports on an overview of key enablers of acceleration/pandemic and preparedness,
covering CMC strategies as well as technical innovations in vaccine development. …

Clinical trial design and dissemination: comprehensive analysis of clinicaltrials. gov and PubMed data since 2005

M Zwierzyna, M Davies, AD Hingorani, J Hunter - Bmj, 2018 - bmj.com
Objective To investigate the distribution, design characteristics, and dissemination of clinical
trials by funding organisation and medical specialty. Design Cross sectional descriptive …

Biological mechanisms of aging predict age‐related disease co‐occurrence in patients

HC Fraser, V Kuan, R Johnen, M Zwierzyna… - Aging …, 2022 - Wiley Online Library
Genetic, environmental, and pharmacological interventions into the aging process can
confer resistance to multiple age‐related diseases in laboratory animals, including rhesus …

Computational design of mRNA vaccines

YA Kim, K Mousavi, A Yazdi, M Zwierzyna, M Cardinali… - Vaccine, 2023 - Elsevier
mRNA technology has emerged as a successful vaccine platform that offered a swift
response to the COVID-19 pandemic. Accumulating evidence shows that vaccine efficacy, …

Design and characterization of chemical space networks for different compound data sets

M Zwierzyna, M Vogt, GM Maggiora… - Journal of computer-aided …, 2015 - Springer
Chemical Space Networks (CSNs) are generated for different compound data sets on the
basis of pairwise similarity relationships. Such networks are thought to complement and further …